$XAGE 4 SEC Filings

Filed On	Filing
08 Apr 2026	Form 4: Ajjarapu J. Ram, Director Bought 689,656 shares ($200K)
08 Nov 2024	Form 4: Bracken-Ferguson Kendra, Chief Executive Officer Granted 378,705 Stock Option (right to buy)
08 Nov 2024	Form 4: Cassaday Bryan J., Chief Financial Officer Granted 120,000 Stock Option (right to buy)
08 Nov 2024	Form 4: Spenlehauer Gilles, Director Granted 76,878 Stock Option (right to buy)
08 Nov 2024	Form 4: Sturgeon Patrick A, Director Granted 76,878 Stock Option (right to buy)
08 Nov 2024	Form 4: Upton Richard A, Director Granted 76,878 Stock Option (right to buy)
08 Nov 2024	Form 4: Gregory Kathryn, Director Granted 76,878 Stock Option (right to buy)
08 Nov 2024	Form 4: Shukla Rajiv, Director Granted 876,878 Stock Option (right to buy)
08 Nov 2024	Form 4: Frisch Scott M., Director Granted 76,878 Stock Option (right to buy)
16 Sep 2024	Form 4: Upton Richard A, Director Bought 5,000 shares ($2.34K)
10 Sep 2024	Form 4: Gregory Kathryn, Director Bought 1,260 shares ($643)
10 Sep 2024	Form 4: Sturgeon Patrick A, Director Bought 1,261 shares ($643)
10 Sep 2024	Form 4: Cassaday Bryan J., Chief Financial Officer Bought 475 shares ($219)
10 Sep 2024	Form 4: Frisch Scott M., Director Bought 1,009 shares ($515)
10 Sep 2024	Form 4: Spenlehauer Gilles, Director Bought 1,009 shares ($515)
04 Sep 2024	Form 4: Gregory Kathryn, Director Bought 109 shares ($62.1)
04 Sep 2024	Form 4: Frisch Scott M., Director Bought 87 shares ($49.6)
04 Sep 2024	Form 4: Sturgeon Patrick A, Director Bought 109 shares ($62.1)
04 Sep 2024	Form 4: Spenlehauer Gilles, Director Bought 87 shares ($49.6)
30 Aug 2024	Form 4: Sturgeon Patrick A, Director Bought 970 shares ($543) · Bought 652 shares ($365)

Comments